Peptides Trace

$PEPTIDES DXeFYzymajq99GKVfAqhmSgjFrdDEAC7AiKJn7UPpump The peptide market runs on unverifiable claims. forged COAs. recycled reports. reputation built on forum posts. PepTrace anchors every lab report on Solana via SAS- cryptographically signed, IPFS-pinned, immutable. trust the COA, not the seller.

Hello everyone again. You can start jumping on Discord. More threads and channels will be opened. Meanwhile you can start joining and making new frens. discord.gg/N5gRdRPVs6

@BioProtocol "Autonomous science needs a surface where claims, conviction, and capital move together." This is why we are all here building

The best self-driving lab in the world still stops and waits. Not for equipment. For a human to decide what comes next. The decision layer is what autonomous science needs🧵

Peptides and AI are bringing back Darwins evolutionary theory Survival of the fittest

This is exactly why we’re building PepTrace. And it is great to see how #DeSci develops in this direction and we see more researchers and projects working on this filed. And we are happy to contribute. Big respect to teams and people pushing real testing and transparency forward. 🧬 The peptide ecosystem desperately needs transparent, verifiable, public infrastructure for: - COAs - purity analysis - lab testing - provenance - supplier accountability Most trust today is fragmented across forums, screenshots, and unverifiable PDFs. The future is immutable evidence, transparent verification, and open scientific standards.

@sciencera_ofc 🫡 We are on the same boat! Let's make smth. big together. My vision as a team member is that all pharmaceuticals must be transparent.

Excited to see more teams in DeSci pushing real peptide work and on-chain transparency (COA publication is a good step). The bigger challenge remains the full translation path after initial testing: From raw sequence → codon optimization → epitope prediction → GLP validation → regulatory evidence → milestone funding → real-world application across 6 verticals. We’re building exactly that infrastructure layer on Solana: → Sequence Layer (mRNA Codon Optimizer + Vaccine Epitope Predictor) → Copilot Knowledge Layer (real PubMed, no hallucination) → Research Portal with tamperproof provenance → Soulbound reputation + verified labs Discovery and early testing are accelerating. Translation infrastructure is what turns candidates into products. sciencera.tech

Quick upd: finishing discord setup - sharing link in an hour and half.

@Mars_DeFi great job. hope to appear in your list soon.

DeSci’s market cap has reached $384M as AI agents compress peptide drug discovery into 24-hour research pipelines. But the real breakthrough is not the tokens, it’s the open-source biotech infrastructure replacing traditional pharma research systems. Here’s the real state of DeSci 2026. — ● The Open-Source AI Stack Powering DeSci The current DeSci momentum accelerated after peptAI reportedly designed an ADHD peptide candidate in 24 hours for only a few thousand dollars. Historically, drug discovery required years of research, massive pharma teams, and millions in upfront R&D. The infrastructure driving this shift includes: • OpenFold3 (by @open_fold) : open-source protein folding infrastructure. • RFdiffusion3 (by lead researcher @r_krishna3) : AI-driven protein and peptide generation. • Boltz-2 ( @Boltz_bio ): high-speed protein binding prediction. • ChEMBL ( @ChEMBL ) : open database with millions of bioactive compounds. • Federated protein training : collaborative biological AI training. • AI peptide agents : autonomous peptide discovery systems. • Bioactivity databases : open molecular research infrastructure. The real shift is biotech infrastructure moving from closed pharma systems onto open-source software rails. Projects like @Peptoma_xyz, @peptome_ai ( $PEPT ), @clarity_proto ( $FOLD ), and @BioLLM_ are building around AI-driven peptide discovery and on-chain biotech funding. — ● The Timeline Bottleneck AI Still Hasn’t Solved AI is accelerating discovery pipelines, but clinical validation remains the hardest challenge in biotech. Phase I: confirms the drug is safe for further testing. Phase II: determines whether the treatment actually works. Phase III: validates efficacy and safety before regulatory approval. AI is improving research speed and molecule discovery, but drug development still operates on multi-year timelines. No AI-designed drug has completed Phase III yet. — ● Updated 2026 DeSci Ecosystem Landscape Despite remaining a sub-$400M sector, DeSci led 24H narrative performance with a 1.64% gain while most major sectors stayed in red. The ecosystem is now expanding across specialized bioDAOs, AI-native discovery, scientific infrastructure, tokenized IP, and analytical tooling. • Capital Coordination Layer : funding decentralized scientific research. @vitadao @athenabiorg @anagenxyz @psy_dao @cryodao @spark_sciences @Spine_DAO @endrarediseases @QuantumBioDAO @Cerebrum_DAO @GenomesDAO @PoSciDonDAO @daohydra @eticaprotocol • AI Discovery Layer : AI-native drug discovery and biological modeling. @GeneStackDeBio @BioLLM_ @clarity_proto @Aubrai_ @Rejuve_AI @DeSci_Agents @cyberphysicsai • IP & Commercialization Layer : tokenizing biotech intellectual property. @Molecule_sci @AxonDAO • Data & Infrastructure Layer : decentralized scientific data and compute infrastructure. @origin_trail @GaleonCare @Hippo_Protocol @BluzelleHQ @GridcoinNetwork @dynexcoin @DataLakeToken @silencioNetwork • Publishing & Knowledge Layer : open-access publishing and peer review systems. @ResearchHub @nobleblocks • Consumer & Speculative Layer : retail biotech participation and experimental markets. @pumpdotscience @Open_Genome @D1ckGPT @peptidefolio • Analytical Tools : DeSci analytics, dashboards, and sector intelligence. @desciatoms @DeSciDashboard @TrackedBio @TBDeSci — ● Where DeSci Is Falling Behind DeSci still struggles with the mismatch between crypto’s short-term capital cycles and biotech’s long research timelines. Markets are pricing scientific potential far earlier than clinical validation, while funding volatility and governance inefficiencies continue slowing long-term research execution. That remains the biggest structural weakness in the DeSci narrative today. — ● Bull Case For DeSci The long-term opportunity is DeSci evolving into a new financing layer for biotech research. AI lowers research costs → bioDAOs fund experiments → IP gets tokenized → successful discoveries generate licensing revenue. That is why the global DeSci funding DAO market is projected to grow from $120M in 2025 to $520M by 2034, reflecting a 17.7% CAGR as scientific funding increasingly moves on-chain. — ● Bear Case For DeSci DeSci still faces major risks around regulation, DAO governance, tokenized IP legality, and integration with traditional academic institutions. Many early-stage DeSci projects still struggle with sustainable funding, researcher onboarding, and maintaining scientific rigor during speculative market cycles. The infrastructure trend is real, but scalable adoption and long-term value capture remain largely unproven. Still, DeSci remains one of the few crypto sectors attempting to build long-duration infrastructure beyond purely financial speculation.

@DeSciDashboard @BioProtocol need to check. looks promising

AUBRAI deep dive just shipped descidash.com/projects/aubrai BioAgent #1 from @BioProtocol + @vitadao. Aubrey de Grey's lab, instantiated as an agent. The template every BioAgent launch since has copied 13 sections. Every receipt. Including the 2021 reset #DeSci

@valley_dao @PrimordiaGrants @techno0ptimist based. desci is warming up for the supercycle

The response to @PrimordiaGrants has been eye-opening! 🎙️ In this Proof of DeSci clip, @techno0ptimist talks about the wave of support the initiative received and why it revealed something important: People want a new way to interact with biotech.

@bella_turkiye @Nanovita_Labs Congrats. Strong partnership.

🚀 @Nanovita_Labs ile iş birliği yapmaktan büyük heyecan duyuyoruz! NanoVita Labs ve Bella Protocol, akıllı ajanların sağlıkla ilgili verileri ve zincir üzerindeki sinyalleri eyleme geçirilebilir öngörülere dönüştürmeye yardımcı olduğu, sosyal odaklı bir DeSci × AI paradigması oluşturuyor. DeSci, Web3 ve otonom ajanların bir araya geldiğinde neler olabileceğini araştırıyoruz. 🧬🤖

@CryptoStacksss Check PepTrace platfrom and $COA. we've just started.

Whenever I tend to share a full ass thesis, it tends to do well. Everyone is jumping on the $VEILNET train but I shared with you a full essay while it’s a gem when it was 60-70k Just French kissed 400k now and we are still early Their privacy FHE dex is coming soon too so I expect this one to just keep going too Shit like this gets dropped regularly on the channel so don’t miss out t.me/Stacksendors

The future of #DeSci is already coded. Researchers, scientists, and enthusiasts uniting on transparent, borderless infrastructure - where ideas fund themselves, data is owned by creators, breakthroughs accelerate in real time, and science escapes gatekeepers forever. This is the ignition of the DeSci Supercycle. The PepTrace is open. The revolution is decentralized. Who’s in?

Not all peptide COAs are created equal. A real review looks beyond the purity % and asks: - Does the chromatogram show a clean peak? - Does the m/z match the expected molecular weight? - Are there unidentified impurity peaks? - Is the retention time consistent across batches? That's why we required a deeper approval for COAs and this is the PepTrace Mission here.

@KhanOffchain Soon. Follow X account and announcements.

@pep_trace Wen launch ?

We are launching what we are currently working on - PepTrace.xyz - a transparent on-chain platform for research peptides. The problem is simple: too many fake COAs and recycled lab reports. Our plan is to fix it with real transparency: - Verified suppliers upload official tests (HPLC, LC-MS, etc.), everything is stored permanently on IPFS and anchored on @solana . - Researchers and everyday users can also submit independent tests - after DAO review. No more blind trust. Only cryptographic proof + community governance. We are still working on improving the main features. Final version is coming.